OpenEvidence Raises $250 Million at $15 Billion Valuation in Biggest Healthcare AI Deal

OpenEvidence, a company specializing in applying artificial intelligence to the healthcare sector, announced the completion of a massive $250 million funding round at a reported valuation of $15 billion. This round is one of the most prominent funding deals in the health tech sector, cementing artificial intelligence's position as a fundamental transformation in the global healthcare system.

Reports indicated that OpenEvidence provides a specialized AI platform that helps physicians and healthcare professionals make evidence-based medical decisions by analyzing millions of peer-reviewed medical research papers and studies in seconds. The product is seeing growing adoption among physicians in major hospitals and clinics.

In the same context, this funding comes amid a broad investment wave in health AI technologies, driven by the sector's immense potential to improve care quality, reduce costs, and accelerate diagnosis and treatment. Investors believe that health AI will radically reshape the trajectory of the medical industry in the coming years.

Health tech experts point out that OpenEvidence's high valuation reflects investor confidence that evidence-based health AI will become an essential standard in global medical practice. The Arab region represents a promising market for these technologies amid rising government investments in the digital transformation of the health sector.